Journal of Clinical Oncology, Vol 15, 3201-3207, Copyright © 1997 by American Society of Clinical Oncology

ARTICLES

Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density

I Persson, E Thurfjell and L Holmberg
Department of Cancer Epidemiology, University Hospital, Uppsala, Sweden.

PURPOSE: Hormone replacement therapy (HRT) may increase the mammographic density with a possible reduction in the sensitivity or specificity. If so, the benefit of mammographic screening in women using HRT could be compromised. We evaluated the hypothesis that HRT regimens have differential effects on the mammographic density depending on treatment regimens or on age. PATIENTS AND METHODS: Among 31,498 Swedish women who received mammographic screening, we selected 554 women who started HRT after the first examination and who were current users at the second, and 554 age-matched women who had never received HRT. Mammograms were examined in a blinded review. The changes in density between the two examinations, graded as moderate or weak reduction, no change, or weak, moderate, or substantial increase, were assessed. We studied four HRT regimens-estradiol compounds only, estradiol compounds cyclically or continuously combined with progestins, and weak estrogens-and used descriptive statistics and logistic regression to analyze the association between HRT and density change. RESULTS: Density increased in 10% and 28% of women who received estradiol compounds with cyclically or continuously combined progestins, respectively, but in only 3% of unexposed women. Logistic regression analyses showed an elevated risk of a density increase (relative risk [RR] = 3.6; 95% confidence interval [CI], 1.6 to 7.7) in women who received cyclically combined regimens or continuously combined regimens (RR = 12.4; 95% CI, 6.3 to 24.4) compared with unexposed women. Women > or = 50 years of age had even stronger associations; RRs in women on estradiol only, the cyclically combined and the continuously combined regimens were 32.2 (95% CI, 3.9 to 267.5), 21.9 (95% CI, 1.9 to 251.5), and 176.9 (95% CI, 22.8 to 1,372.7), respectively. CONCLUSION: HRT with estradiol-progestin regimens, especially continuously combined, may increase the mammographic density in a substantial proportion of women.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H. L. Jordan, J. L. Hopper, R. J. Thomson, A. M. Kavanagh, D. M. Gertig, J. Stone, and A. J. Venn Influence of High-Dose Estrogen Exposure during Adolescence on Mammographic Density for Age in Adulthood Cancer Epidemiol. Biomarkers Prev., January 1, 2010; 19(1): 121 - 129. [Abstract] [Full Text] [PDF]

				A. McTiernan, R. T. Chlebowski, C. Martin, J. D. Peck, A. Aragaki, E. D. Pisano, C.Y. Wang, K. C. Johnson, J. E. Manson, R. B. Wallace, et al. Conjugated Equine Estrogen Influence on Mammographic Density in Postmenopausal Women in a Substudy of the Women's Health Initiative Randomized Trial J. Clin. Oncol., December 20, 2009; 27(36): 6135 - 6143. [Abstract] [Full Text] [PDF]

				R. M. Tamimi, C. Byrne, G. A. Colditz, and S. E. Hankinson Endogenous Hormone Levels, Mammographic Density, and Subsequent Risk of Breast Cancer in Postmenopausal Women J Natl Cancer Inst, August 1, 2007; 99(15): 1178 - 1187. [Abstract] [Full Text] [PDF]

				F. J.B. van Duijnhoven, P. H.M. Peeters, R. M.L. Warren, S. A. Bingham, P. A.H. van Noord, E. M. Monninkhof, D. E. Grobbee, and C. H. van Gils Postmenopausal Hormone Therapy and Changes in Mammographic Density J. Clin. Oncol., April 10, 2007; 25(11): 1323 - 1328. [Abstract] [Full Text] [PDF]

				G. J. R. Porter, A. J. Evans, E. J. Cornford, H. C. Burrell, J. J. James, A. H. S. Lee, and J. Chakrabarti Influence of Mammographic Parenchymal Pattern in Screening-Detected and Interval Invasive Breast Cancers on Pathologic Features, Mammographic Features, and Patient Survival Am. J. Roentgenol., March 1, 2007; 188(3): 676 - 683. [Abstract] [Full Text] [PDF]

				P. A. Carney, E. Steiner, M. E. Goodrich, A. J. Dietrich, C. J. Kasales, J. E. Weiss, and T. MacKenzie Discovery of Breast Cancers Within 1 Year of a Normal Screening Mammogram: How Are They Found? Ann. Fam. Med, November 1, 2006; 4(6): 512 - 518. [Abstract] [Full Text] [PDF]

				A. M. Chiarelli, V. A. Kirsh, N. S. Klar, R. Shumak, R. Jong, E. Fishell, M. J. Yaffe, and N. F. Boyd Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1856 - 1862. [Abstract] [Full Text] [PDF]

				C. J. Fabian and B. F. Kimler Mammographic Density: Use in Risk Assessment and as a Biomarker in Prevention Trials J. Nutr., October 1, 2006; 136(10): 2705S - 2708S. [Full Text] [PDF]

				F. J.B. van Duijnhoven, P. H.M. Peeters, R. M.L. Warren, S. A. Bingham, A. G. Uitterlinden, P. A.H. van Noord, E. M. Monninkhof, D. E. Grobbee, and C. H. van Gils Influence of Estrogen Receptor {alpha} and Progesterone Receptor Polymorphisms on the Effects of Hormone Therapy on Mammographic Density. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 462 - 467. [Abstract] [Full Text] [PDF]

				R. M. Tamimi, S. E. Hankinson, G. A. Colditz, and C. Byrne Endogenous Sex Hormone Levels and Mammographic Density among Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2641 - 2647. [Abstract] [Full Text] [PDF]

				A. McTiernan, C. F. Martin, J. D. Peck, A. K. Aragaki, R. T. Chlebowski, E. D. Pisano, C. Y. Wang, R. L. Brunner, K. C. Johnson, J. E. Manson, et al. Estrogen-Plus-Progestin Use and Mammographic Density in Postmenopausal Women: Women's Health Initiative Randomized Trial J Natl Cancer Inst, September 21, 2005; 97(18): 1366 - 1376. [Abstract] [Full Text] [PDF]

				F.-P. Chen, Y.-C. Cheung, L.-F. Teng, and Y.-K. Soong The relationship between mammographic density and duration of hormone therapy: effects of estrogen and estrogen-progestin Hum. Reprod., June 1, 2005; 20(6): 1741 - 1745. [Abstract] [Full Text] [PDF]

				J.-P. Delille, P. J. Slanetz, E. D. Yeh, D. B. Kopans, E. F. Halpern, and L. Garrido Hormone Replacement Therapy in Postmenopausal Women: Breast Tissue Perfusion Determined with MR Imaging--Initial Observations Radiology, April 1, 2005; 235(1): 36 - 41. [Abstract] [Full Text] [PDF]

				L. A. Habel, J. J. Dignam, S. R. Land, M. Salane, A. M. Capra, and T. B. Julian Mammographic Density and Breast Cancer After Ductal Carcinoma In Situ J Natl Cancer Inst, October 6, 2004; 96(19): 1467 - 1472. [Abstract] [Full Text] [PDF]

				J. H. Lai, D. Vesprini, W. Zhang, M. J. Yaffe, M. Pollak, and S. A. Narod A Polymorphic Locus in the Promoter Region of the IGFBP3 Gene Is Related to Mammographic Breast Density Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 573 - 582. [Abstract] [Full Text] [PDF]

				E. O. Lillie, L. Bernstein, S. A. Ingles, W. J. Gauderman, G. E. Rivas, V. Gagalang, T. Krontiris, and G. Ursin Polymorphism in the Androgen Receptor and Mammographic Density in Women Taking and Not Taking Estrogen and Progestin Therapy Cancer Res., February 15, 2004; 64(4): 1237 - 1241. [Abstract] [Full Text] [PDF]

				J. A. Harvey and V. E. Bovbjerg Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk Radiology, January 1, 2004; 230(1): 29 - 41. [Abstract] [Full Text] [PDF]

				P. A. Carney, D. L. Miglioretti, B. C. Yankaskas, K. Kerlikowske, R. Rosenberg, C. M. Rutter, B. M. Geller, L. A. Abraham, S. H. Taplin, M. Dignan, et al. Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography Ann Intern Med, February 4, 2003; 138(3): 168 - 175. [Abstract] [Full Text] [PDF]

				R. T. Chlebowski and A. McTiernan Biological Significance of Interventions That Change Breast Density J Natl Cancer Inst, January 1, 2003; 95(1): 4 - 5. [Full Text] [PDF]

				G. A. Greendale, B. A. Reboussin, S. Slone, C. Wasilauskas, M. C. Pike, and G. Ursin Postmenopausal Hormone Therapy and Change in Mammographic Density J Natl Cancer Inst, January 1, 2003; 95(1): 30 - 37. [Abstract] [Full Text] [PDF]

				C. J. Fabian, B. F. Kimler, D. A. Brady, M. S. Mayo, C. H. J. Chang, J. A. Ferraro, C. M. Zalles, A. L. Stanton, S. Masood, W. E. Grizzle, et al. A Phase II Breast Cancer Chemoprevention Trial of Oral {alpha}-Difluoromethylornithine: Breast Tissue, Imaging, and Serum and Urine Biomarkers Clin. Cancer Res., October 1, 2002; 8(10): 3105 - 3117. [Abstract] [Full Text] [PDF]

				J M Dixon Hormone replacement therapy and the breast BMJ, December 15, 2001; 323(7326): 1381 - 1382. [Full Text] [PDF]

				M. Freedman, J. S. Martin, J. O'Gorman, S. Eckert, M. E. Lippman, S.-C. B. Lo, E. L. Walls, and J. Zeng Digitized Mammography: a Clinical Trial of Postmenopausal Women Randomly Assigned to Receive Raloxifene, Estrogen, or Placebo J Natl Cancer Inst, January 3, 2001; 93(1): 51 - 56. [Abstract] [Full Text] [PDF]

				R. J. Santen, J. Pinkerton, C. McCartney, and G. R. Petroni Risk of Breast Cancer with Progestins in Combination with Estrogen as Hormone Replacement Therapy J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 16 - 23. [Full Text]

				L. A. Bazzano, G. Del Priore, M.-J. Lee, A. N. Glaser, J. A. Harvey, C. J. Newschaffer, K. J. Helzlsouer, C. A. Roca, P. J. Schmidt, R. C. Daly, et al. Estrogen-Progestin Replacement and Risk of Breast Cancer JAMA, August 9, 2000; 284(6): 691 - 694. [Full Text] [PDF]

				E. Sala, R. Warren, J. McCann, S. Duffy, R. Luben, and N. Day High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study Int. J. Epidemiol., August 1, 2000; 29(4): 629 - 636. [Abstract] [Full Text] [PDF]

				A. Trentham-Dietz, P. A. Newcomb, B. E. Storer, and P. L. Remington Risk Factors for Carcinoma in Situ of the Breast Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 697 - 703. [Abstract] [Full Text]

				B. Fowble, A. Hanlon, G. Freedman, A. Patchefsky, H. Kessler, N. Nicolaou, J. Hoffman, E. Sigurdson, M. Boraas, and L. Goldstein Postmenopausal Hormone Replacement Therapy: Effect on Diagnosis and Outcome in Early-Stage Invasive Breast Cancer Treated With Conservative Surgery and Radiation J. Clin. Oncol., June 1, 1999; 17(6): 1680 - 1680. [Abstract] [Full Text] [PDF]

				C. J. Baines and R. Dayan A Tangled Web: Factors Likely to Affect the Efficacy of Screening Mammography J Natl Cancer Inst, May 19, 1999; 91(10): 833 - 838. [Full Text] [PDF]

				ESTROGENS INCREASE BREAST DENSITY ON MAMMOGRAPHY Journal Watch (General), October 24, 1997; 1997(1024): 2 - 2. [Full Text]